Animal-free cryopreservation media are specialized formulations designed to preserve cells, tissues, and other biological materials at ultralow temperatures without the inclusion of any animal-derived components at any stage of the manufacturing process. The term "animal-free" represents the most stringent classification in the hierarchy of cryopreservation media, denoting the complete absence of materials of animal origin, including fetal bovine serum (FBS), bovine serum albumin (BSA), porcine trypsin, and other xenogeneic biological products. This distinguishes animal-free media from related but distinct classifications: serum-free media exclude serum but may contain animal-derived proteins; xeno-free media exclude non-human species components but permit human-derived materials; and animal component-free (ACF) media exclude all animal-derived components but may permit human-derived materials.
The development of animal-free cryopreservation media has been driven by converging scientific, regulatory, and ethical imperatives. Traditional cryopreservation protocols have relied on FBS as a key protective component, typically at concentrations of 20–90% combined with 5–10% dimethyl sulfoxide (DMSO). However, FBS introduces substantial challenges: its composition varies greatly between lots, it carries risks of contamination with viruses, prions, and mycoplasma, and it contains undefined bioactive factors that can unpredictably affect cell physiology. For clinical applications, animal-derived proteins can induce immunological reactions, and residual animal-derived content complicates regulatory filings.
Applications
Cell therapy manufacturing. Cryopreservation is central to the manufacturing of CAR-T cells, NK cells, mesenchymal stem cells, and other advanced therapy medicinal products. Traditional formulations use 5–10% DMSO with human serum albumin or serum, while animal-free alternatives are increasingly preferred for regulatory compliance.
Biobanking. Animal-free media enable the long-term storage of cells, tissues, and biological samples in biorepositories. PBMCs cryopreserved in animal-protein-free media maintained high viability and functionality for up to 2 years.
Stem cell research. Human pluripotent stem cells, including embryonic stem cells and induced pluripotent stem cells, are cryopreserved in defined, xeno-free, animal-free media.
Regenerative medicine. Xeno-free cryopreservation of human amnion-derived stem cells is feasible and can be standardized to establish a bio-bank for future clinical application. The freezing medium used for cryopreservation of cells administered to humans for regenerative medicine must be xeno-free.